A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Smithfield lease Mass. biotech offered millions to manufacture skin in R.I. Boston biotech aims to put some skin in the RI ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to ...

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

The measles outbreak in Texas has slowed, with only one new case added between May 13 and May 16. There are confirmed cases ...

The Janus Henderson Global Life Sciences Fund returned 0.99% and the MSCI World Health Care IndexSM returned 5.10% for Q1 ...

A new frontier into advancing treatments for children and adults with bone marrow failure, leukaemia and other blood disorders will be achieved under a new partnership between Murdoch Children's ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...